Bayer trims 2 top execs, shrinks management board; SpringWorks boosts size of IPO
→ After welcoming J&J dealmaker Marianne De Backer to their team as BD chief a little more than a week ago, Bayer announced that it will be reducing the size of the company’s board of management. Hartmut Klusik and Kemal Malik will be hitting the exit and the company doesn’t plan on retaining those positions — taking the board from seven to five members.
According to the company, as of January 1, 2020, the board of management will consist of chairman Werner Baumann, CFO Wolfgang Nickl and division presidents Liam Condon (Crop Science), Stefan Oelrich (Pharmaceuticals) and Heiko Schipper (Consumer Health).
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.